Therefore, lower MCP-4 levels might lead to disease development, and higher inflammatory response exhibited by higher MCP-4 levels reduces symptoms of MDD that can explain the elevated levels of MCP-4 in MDD patients with a negative correlation with disease severity [66]. This evidence concerns the gene CCL13 and major depressive disorder.